Ophthalmic Sciences

Company Overview

Snapshot

Founded in August 2019, Ophthalmic Sciences operates with 1–10 employees. The company has raised $2.32M across 3 funding rounds from 2 investors. In February 2023, eHealth Ventures participated in a funding round, underscoring continued investor confidence.

Business overview

Ophthalmic Sciences develops the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device for in-home telemedicine. This mobile product utilizes a VR-like headset and artificial intelligence algorithms to analyze captured video imaging, providing fast, reliable, and user-friendly IOP measurements, a critical biomarker for glaucoma monitoring and treatment. The company's tonometer solution enables highly accurate asynchronous remote monitoring, serving ophthalmologists, optometrists, clinics, hospitals, and telehealth providers by improving patient outcomes and reducing costs.

Strategic signal

In November 2022, Ophthalmic Sciences initiated recruitment at Assuta Hashalom, Israel's busiest eye clinic, marking the testing initiation of its most advanced prototype. This development signals a critical step forward in the company's product validation and clinical readiness, demonstrating progress towards commercialization and real-world application of its telemedicine device for glaucoma management.

Company Intelligence Q&A

What is the primary product developed by Ophthalmic Sciences?

Ophthalmic Sciences has developed the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device designed for in-home telemedicine.

When did Ophthalmic Sciences initiate recruitment for clinical testing of its advanced prototype?

In November 2022, Ophthalmic Sciences initiated recruitment at Assuta Hashalom, marking the testing initiation of its most advanced prototype.

Which investor participated in a funding round for Ophthalmic Sciences in February 2023?

In February 2023, eHealth Ventures participated in a funding round for Ophthalmic Sciences.

What technology does the IOPerfect device utilize for eye fluid pressure measurement?

The IOPerfect device uses a VR-like headset and artificial intelligence algorithms to analyze captured video imaging for measuring intraocular pressure.

When did Ophthalmic Sciences secure financing that was announced in January 2022?

Ophthalmic Sciences secured financing in January 2022, with eHealth Ventures participating in the round.